These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 21029179)

  • 21. Cardiac allograft vasculopathy by intravascular ultrasound in heart transplant patients: substudy from the Everolimus versus mycophenolate mofetil randomized, multicenter trial.
    Kobashigawa JA; Pauly DF; Starling RC; Eisen H; Ross H; Wang SS; Cantin B; Hill JA; Lopez P; Dong G; Nicholls SJ;
    JACC Heart Fail; 2013 Oct; 1(5):389-99. PubMed ID: 24621971
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antibodies against heterogeneous nuclear ribonucleoprotein K in patients with cardiac allograft vasculopathy.
    Acevedo MJ; Caro-Oleas JL; Álvarez-Márquez AJ; Sobrino JM; Lage-Gallé E; Aguilera I; Núñez-Roldán A
    J Heart Lung Transplant; 2011 Sep; 30(9):1051-9. PubMed ID: 21489814
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Virtual histology intravascular ultrasound assessment of cardiac allograft vasculopathy from 1 to 20 years after heart transplantation.
    Hernandez JM; de Prada JA; Burgos V; Sainz Laso F; Valls MF; Vilchez FG; Llano M; Ruano J; Zueco J; Colman T; Duran RM
    J Heart Lung Transplant; 2009 Feb; 28(2):156-62. PubMed ID: 19201341
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Detection and imaging of cardiac allograft vasculopathy.
    Pollack A; Nazif T; Mancini D; Weisz G
    JACC Cardiovasc Imaging; 2013 May; 6(5):613-23. PubMed ID: 23680373
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intravascular ultrasound of the proximal left anterior descending artery is sufficient to detect early cardiac allograft vasculopathy.
    Floré V; Brown AJ; Pettit SJ; West NEJ; Lewis C; Parameshwar J; Hoole SP
    Clin Transplant; 2018 Feb; 32(2):. PubMed ID: 29194769
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Multicenter intravascular ultrasound validation study among heart transplant recipients: outcomes after five years.
    Kobashigawa JA; Tobis JM; Starling RC; Tuzcu EM; Smith AL; Valantine HA; Yeung AC; Mehra MR; Anzai H; Oeser BT; Abeywickrama KH; Murphy J; Cretin N
    J Am Coll Cardiol; 2005 May; 45(9):1532-7. PubMed ID: 15862430
    [TBL] [Abstract][Full Text] [Related]  

  • 27. How to Approach the Assessment of Cardiac Allograft Vasculopathy in the Modern Era: Review of Invasive Imaging Modalities.
    Javaheri A; Saha N; Lilly SM
    Curr Heart Fail Rep; 2016 Apr; 13(2):86-91. PubMed ID: 26879390
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Low-dose unfractionated heparin administration during intravascular ultrasound studies is safe even shortly after endomyocardial biopsy in cardiac transplant patients.
    Arsanjani R; Khitri A; Hashemzadeh M; Movahed MR
    J Invasive Cardiol; 2012 Apr; 24(4):154-6. PubMed ID: 22477749
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Paradoxical Vessel Remodeling of the Proximal Segment of the Left Anterior Descending Artery Predicts Long-Term Mortality After Heart Transplantation.
    Okada K; Kitahara H; Yang HM; Tanaka S; Kobayashi Y; Kimura T; Luikart H; Yock PG; Yeung AC; Valantine HA; Fitzgerald PJ; Khush KK; Honda Y; Fearon WF
    JACC Heart Fail; 2015 Dec; 3(12):942-52. PubMed ID: 26577615
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differential effect of everolimus on progression of early and late cardiac allograft vasculopathy in current clinical practice.
    Masetti M; Potena L; Nardozza M; Prestinenzi P; Taglieri N; Saia F; Pece V; Magnani G; Fallani F; Coccolo F; Russo A; Rapezzi C; Grigioni F; Branzi A
    Am J Transplant; 2013 May; 13(5):1217-26. PubMed ID: 23621161
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interplay of coronary angiography and intravascular ultrasound in predicting long-term outcomes after heart transplantation.
    Potena L; Masetti M; Sabatino M; Bacchi-Reggiani ML; Pece V; Prestinenzi P; Dall'Ara G; Taglieri N; Saia F; Fallani F; Magnani G; Rapezzi C; Grigioni F
    J Heart Lung Transplant; 2015 Sep; 34(9):1146-53. PubMed ID: 25843518
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Donor-Transmitted Atherosclerosis Associated With Worsening Cardiac Allograft Vasculopathy After Heart Transplantation: Serial Volumetric Intravascular Ultrasound Analysis.
    Watanabe T; Seguchi O; Yanase M; Fujita T; Murata Y; Sato T; Sunami H; Nakajima S; Kataoka Y; Nishimura K; Hisamatsu E; Kuroda K; Okada N; Hori Y; Wada K; Hata H; Ishibashi-Ueda H; Miyamoto Y; Fukushima N; Kobayashi J; Nakatani T
    Transplantation; 2017 Jun; 101(6):1310-1319. PubMed ID: 27472091
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Computed tomography imaging of cardiac allograft vasculopathy.
    Ferencik M; Brady TJ; Hoffmann U
    J Cardiovasc Comput Tomogr; 2012; 6(4):223-31. PubMed ID: 22732195
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vivo comparison between cardiac allograft vasculopathy and native atherosclerosis using near-infrared spectroscopy and intravascular ultrasound.
    Zheng B; Maehara A; Mintz GS; Nazif TM; Waksman Y; Qiu F; Jaquez L; Rabbani LE; Apfelbaum MA; Ali ZA; Dalton K; Xu K; Marboe CC; Mancini DM; Weisz G
    Eur Heart J Cardiovasc Imaging; 2015 Sep; 16(9):985-91. PubMed ID: 25719180
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Coronary atherosclerosis with vulnerable plaque and complicated lesions in transplant recipients: new insight into cardiac allograft vasculopathy by optical coherence tomography.
    Cassar A; Matsuo Y; Herrmann J; Li J; Lennon RJ; Gulati R; Lerman LO; Kushwaha SS; Lerman A
    Eur Heart J; 2013 Sep; 34(33):2610-7. PubMed ID: 23801824
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Optical coherence tomography and highly sensitivity troponin T for evaluating cardiac allograft vasculopathy.
    Garrido IP; García-Lara J; Pinar E; Pastor-Pérez F; Sánchez-Mas J; Valdés-Chavarri M; Pascual-Figal DA
    Am J Cardiol; 2012 Sep; 110(5):655-61. PubMed ID: 22640973
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The value of routine intracoronary ultrasound to assess coronary artery disease in cardiac allograft recipients.
    Calé R; Almeida M; Rebocho MJ; Aguiar C; Sousa P; Brito J; Varandas E; Figueiredo H; Gonçalves P; Raposo L; Teles R; Machado F; Queirós e Melo J; Silva JA
    Rev Port Cardiol; 2010 Feb; 29(2):231-41. PubMed ID: 20545250
    [TBL] [Abstract][Full Text] [Related]  

  • 38. OCT assessment of allograft vasculopathy in heart transplant recipients.
    Hou J; Lv H; Jia H; Zhang S; Xing L; Liu H; Kong J; Zhang S; Yu B; Jang IK
    JACC Cardiovasc Imaging; 2012 Jun; 5(6):662-3. PubMed ID: 22698538
    [No Abstract]   [Full Text] [Related]  

  • 39. Comparative Study of Pediatric Coronary Allograft Vasculopathy Between Single Centers in North America and United Kingdom.
    Fenton M; Mahmood A; Burch M; Simmonds J; Kuhn MA
    Transplant Proc; 2018 Dec; 50(10):3705-3709. PubMed ID: 30577259
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Monitoring of allograft vasculopathy by intravascular ultrasound one month and one year after heart transplantation: A single center study.
    Bedanova H; Orban M; Tretina M; Fila P; Horvath V; Krejci J; Nemec P
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2016 Mar; 160(1):130-5. PubMed ID: 26220510
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.